Moreover, additional markers identified include EGFR, AP-1, p63, and TGF-β, as their pro-oncogenic functions regulate breast cancer invasiveness, and therefore, these can be exploited as therapeutic targets in breast cancer [44]. This evidence concerns the gene TGFB1 and breast cancer.